Price Chart

Profile

Agentix Corp.is a biotechnology company, which engages in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists, and antagonists which modulate the endocannabinoid system (ECS). The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.
URL http://www.agentixcorp.com
Investor Relations URL N/A
HQ State/Province California
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Agentix Corp.is a biotechnology company, which engages in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists, and antagonists which modulate the endocannabinoid system (ECS). The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.
URL http://www.agentixcorp.com
Investor Relations URL N/A
HQ State/Province California
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A